Want to join the conversation?
$EXAR has leveraged its breadth of IP and expertise with a focus on core successful IP to create winning products. The company has restructured its product lines. $EXAR currently serves a $4Bil market and has around 4% share. The company has Tier 1 engagements underway in each of its product lines. Primary focus is increasing market share to 5%.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?